← All stocks

Damora Therapeutics, Inc.

DMRA Net buying
CIK 0001800315 #2097 in the set updated 17 Sep 2026
Bought (120 mo)
$28.14M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$2.34M
$0.00 on a plan · $38.79K straight out of an exercise
Sold at will
$2.31M
37 of 46 sales
Net
+$25.80M
+$25.83M against sales at will

By person

17 insiders · 63 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Khuong Chau Quang
Director
$11.00M (2)
+$11.00M
1,031,811
$30.93M
ORBIMED ADVISORS LLC entity
10% owner
$11.00M (2)
$2.30M (36)
+$8.70M
2,542,186
$76.21M
+943.8%
Novo Holdings A/S entity
10% owner
$5.00M (1)
+$5.00M
2,497,791
$74.88M
Christgau Stephan
Director
$999.99K (1)
+$999.99K
546,136
$16.37M
Lindmark Bertil
Chief Medical Officer
$42.06K (2)
+$42.06K
16,604
$497.79K
Freve Jonathan
Chief Financial Officer
$41.40K (4)
+$41.40K
12,000
$359.76K
Schambye Hans T.
Chief Executive Officer
$41.83K (3)
$24.96K (3) scheduled
+$16.87K
4,682
$140.37K
Firmani Lori
Chief Financial Officer
$4.86K (3) scheduled
−$4.86K
931
$27.91K
Winslow Garrett
General Counsel
$14.56K (2)
$16.32K (4) scheduled
−$1.76K
2,289
$68.62K
Fairmount Funds Management LLC entity
Director
2,904,000
$87.06M
Jarrett Jennifer
See Remarks
500,000
$14.99M
Hewes L. Becker
Chief Medical Officer
264,629
$7.93M
Sattarzadeh Sherwin
Chief Operating Officer
190,376
$5.71M
Bruno Julianne
Director
137,032
$4.11M
+1,606%
GOLDFISCHER CARL
Director
29,019
$869.99K
Munshi Amit
Director
4,793
$143.69K
Pedersen Anders
Chief Operating Officer
3,746
$112.31K

No percentages here. This company's share count has moved by a factor of 46.9 over the window, from 1,316,989 to 61,735,519 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Firmani Lori
2 Jan 2026
Chief Financial Officer
Sold after exercise
135
$21.41
$2.89K
Winslow Garrett
2 Jan 2026
General Counsel
Sold after exercise
255
$21.38
$5.45K
Schambye Hans T.
2 Jan 2026
Chief Executive Officer
Sold after exercise
700
$21.38
$14.97K
Firmani Lori
3 Jul 2025
Interim CFO
Sold after exercise
147
$3.39
$498.33
Winslow Garrett
3 Jul 2025
General Counsel
Sold after exercise
260
$3.39
$881.40
Schambye Hans T.
3 Jul 2025
Chief Executive Officer
Sold after exercise
735
$3.38
$2.48K
Schambye Hans T.
3 Jan 2025
Chief Executive Officer
Sold after exercise
1,341
$5.60
$7.51K
Firmani Lori
3 Jan 2025
Interim CFO
Sold after exercise
261
$5.63
$1.47K
Winslow Garrett
3 Jan 2025
General Counsel
Sold after exercise
471
$5.60
$2.64K

What was left out

Form 4 filings counted 105
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 10
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 9
Sales at will 37
Transactions with no price 0
Shares from compensation/vesting 19,662,496
History held since 4 Nov 2020